Chemistry:Ridazolol

From HandWiki
Revision as of 20:20, 17 December 2022 by TextAI2 (talk | contribs) (add)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Ridazolol
Ridazolol.svg
Names
IUPAC name
5-Chloro-4-[2-[[3-(2-chlorophenoxy)-2-hydroxypropyl]amino]ethylamino]-1H-pyridazin-6-one
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
Properties
C15H18Cl2N4O3
Molar mass 373.23 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Tracking categories (test):

Ridazolol is a pharmaceutical drug acting as a beta adrenergic receptor antagonist. It was investigated in the 1980 and 90s for its effects on coronary heart disease and essential hypertension (high blood pressure).[1][2]

It is not known to be marketed anywhere in the world.[3]

References

  1. Fach, WA; Starke, E; Becker, HJ (1992). "Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease". Zeitschrift für Kardiologie 81 (6): 320–5. PMID 1353933. 
  2. Rommel, Th.; Demisch, L. (1994). "Influence of chronic ?-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension". Journal of Neural Transmission 95 (1): 39–48. doi:10.1007/BF01283029. PMID 7857585. 
  3. "Ridazolol search results". Drugs.com. https://www.drugs.com/search.php?searchterm=ridazolol. Retrieved 2021-03-31.